Estradiol/nomegestrol intravaginal ring

Drug Profile

Estradiol/nomegestrol intravaginal ring

Alternative Names: MK-8175A intravaginal; NOMAC-CVR; NOMAC/CVR; Nomegestrol acetate contraceptive vaginal ring; Nomegestrol/estradiol intravaginal ring; SCH-900121 intravaginal

Latest Information Update: 21 Aug 2015

Price : $50

At a glance

  • Originator Merck & Co
  • Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Pregnadienes; Progesterone congeners; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Dysmenorrhoea; Pregnancy

Most Recent Events

  • 21 Aug 2015 No recent reports of development identified - Phase-II for Dysmenorrhoea in Norway, Germany, Sweden, Denmark, Spain, Poland and Netherlands (Vaginal)
  • 21 Aug 2015 No recent reports of development identified - Phase-II for Pregnancy (Prevention) in Sweden, Spain, Poland, Norway, Netherlands, Hungary, Denmark, Denmark, Germany and USA (Vaginal)
  • 01 Oct 2013 Merck completes a phase II trial in Contraception/Pregnancy (Prevention) in Denmark, Germany, Hungary, the Netherlands, Norway, Poland, Spain, Sweden, and in the US (NCT01709318)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top